Skip to main content
Top
Published in: Cancer Causes & Control 9/2004

01-11-2004

Familial aggregation of melanoma risks in a large population-based sample of melanoma cases

Authors: Colin B. Begg, Amanda Hummer, Urvi Mujumdar, Bruce K. Armstrong, Anne Kricker, Loraine D. Marrett, Robert C. Millikan, Stephen B. Gruber, Hoda Anton-Culver, Judith B. Klotz, Roberto Zanetti, Richard P. Gallagher, Terence Dwyer, Timothy R. Rebbeck, Marrianne R. Berwick

Published in: Cancer Causes & Control | Issue 9/2004

Login to get access
Metadata
Title
Familial aggregation of melanoma risks in a large population-based sample of melanoma cases
Authors
Colin B. Begg
Amanda Hummer
Urvi Mujumdar
Bruce K. Armstrong
Anne Kricker
Loraine D. Marrett
Robert C. Millikan
Stephen B. Gruber
Hoda Anton-Culver
Judith B. Klotz
Roberto Zanetti
Richard P. Gallagher
Terence Dwyer
Timothy R. Rebbeck
Marrianne R. Berwick
Publication date
01-11-2004
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 9/2004
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10522-004-2474-2

Other articles of this Issue 9/2004

Cancer Causes & Control 9/2004 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine